Publication Cover
Physiotherapy Theory and Practice
An International Journal of Physical Therapy
Volume 40, 2024 - Issue 2
195
Views
2
CrossRef citations to date
0
Altmetric
Descriptive Reports

Validity and reliability of the Persian version of the STarT musculoskeletal tool

, , ORCID Icon, , , & show all
Pages 386-394 | Received 08 Aug 2022, Accepted 19 Oct 2022, Published online: 12 Nov 2022
 

ABSTRACT

Background

The Subgrouping for Targeted Treatment (STarT) musculoskeletal (MSK) tool stratifies patients with MSK disorders (MSDs) into prognostic categories based on poor outcomes.

Purpose

This study aimed at investigating the validity and reliability of the Persian STarT MSK tool in people suffering from painful MSDs in Iran.

Methods

A total of 593 subjects with painful MSDs including neck, shoulder, low back, knee, and multisite pain received and completed the STarT MSK tool, visual analog scale (VAS), EuroQol five-dimensions three-levels questionnaire (EQ-5D-3 L), short form-36 health survey questionnaire (SF-36), and Örebro musculoskeletal pain screening questionnaire (ÖMPSQ) in the first visit. To examine test–retest reliability, 234 patients completed the STarT MSK tool 2 days after the initial visit.

Results

In this study, 139 (23.5%), 266 (44.9%), and 188 (31.7%) participants were classified as low-, medium-, and high-risk groupings for poor outcomes, respectively. Spearman’s correlation coefficient showed a strong relationship among Persian STarT MSK tool and EQ-5D-3 L (−0.78), SF-36 (−0.76), and OMPSQ (0.70). The results of known-group validity indicated that this tool could distinguish among the participants in different risk subgroups based on the scores of the ÖMPSQ, VAS, SF36, and EQ-5D-5 L (p < .001). No ceiling and floor effects were observed. Cronbach’s alpha and intra-class correlation coefficient (ICC2,1) were acceptable (0.71) and excellent (0.98), respectively.

Conclusion

The Persian version of STarT MSK tool has shown to be a valid and reliable instrument to stratify people with painful MSDs into low-, medium-, and high-risk subgroups based on persistent pain disability.

Acknowledgments

This study is part of PhD thesis of Mehrnoosh Karimi. Special thanks to Ahvaz Jundishapur University of Medical Sciences for the financial support (PHT-9816). We sincerely thank Prof. Paul Campbell for permitting us to translate the STarT MSK tool into Persian.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Ahvaz Jundishapur University of Medical Sciences under Grant number: PHT-9816.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.